Clinical Trial Update: DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes [Phase 4]

View source ↗

Summary

Clinical trial evaluating the efficacy and safety of dapagliflozin or pioglitazone in patients with type 2 diabetes (Phase 4; recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• FARXIGA (dapagliflozin)

Snippet

Sponsor: Dong Wha Pharmaceutical Co. Ltd. | Conditions: Type2diabetes | Phase 4 | Status: RECRUITING